Epicrispr Biotechnologies

Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.

Health and bio

TIMELINE · MONEY RAISED

Epicrispr Biotechnologies | 1077 days from X account to first raise on record

@EpicrisprBio·Raised $158M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. August 11, 2026
   Series B+ · $90M
   JJanus Henderson Investors (lead), OOctagon Capital Advisors (lead), AAbrdn, AAngelini Ventures, CCormorant Asset Management, DDuquesne Family Office, FFidelity, RReadout Capital, SSanofi Ventures
   Source: fundraisingfox.com
2. March 26, 2025
   Series B+ · $68M
   AAlly Bridge Group (lead), SSolve FSHD
   Source: finance.yahoo.com
3. April 14, 2022
   X account created
4. January 25, 2018
   Website created

Founders and team

• SQ
  Stanley Qi Founder

  LinkedIn
• AS
  Amber Salzman CEO
• WM
  Weston Miller Chief Medical Officer

Investors

• AAbrdn
• AAlly Bridge Grouplead investor
• AAngelini Ventures
• CCalifornia Institute for Regenerative Medicine
• CCormorant Asset Management
• DDuquesne Family Office
• FFidelity
• JJanus Henderson Investorslead investor
• OOctagon Capital Advisorslead investor
• RReadout Capital
• SSanofi Ventures
• SSolve FSHD

Companies like Epicrispr Biotechnologies

• NNewLimit$435M Series B+ · Jun 2026
• PPAM2L Biotechnologies$29.97M Series A · Oct 2026
• SSensible Biotechnologies$47M Series A · Oct 2026
• RRidge Biotechnologies$38M Seed · Sep 2026
• AArtan Biotechnologies$200K Seed · Jun 2026
• SSRTD Biotech$35.26M Seed · Nov 2026

Other companies backed by Janus Henderson Investors

• CCesiumAstro$730M Series B+ · Nov 2026
• SStar Therapeutics$200M Series B+ · Oct 2026
• OOMass Therapeutics$310M Series B+ · Oct 2026
• SSoufflé Therapeutics$135M Series B+ · Oct 2026
• TTare$13M Seed · Sep 2026
• CClaris Bio$118M Series B+ · Jul 2026

Janus Henderson Investors portfolio →